Table 2.
Comparison of study outcome with different study characteristics.
| Poor outcome, mRS≥3 (n=35) | Good outcome, mRS≤2 (n=29) | Row total | P | ||
|---|---|---|---|---|---|
| Age | 60.77±16.42 | 59.62±14.12 | 0.67a | ||
| Sex, n (%) | |||||
| Male | 17 (45.9) | 20 (54.1) | 37 (100.0) | 0.10 | |
| Female | 18 (66.7) | 9 (33.3) | 27 (100.0) | ||
| Address, n (%) | |||||
| Inside valley | 12 (66.7) | 6 (33.3) | 18 (100.0) | 0.22 | |
| Outside valley | 23 (50.0) | 23 (50.0) | 46 (100.0) | ||
| Stroke type, n (%) | |||||
| LVO | 21 (67.7) | 10 (32.3) | 31 (100.0) | 0.08 b | |
| Lacunar | 5 (38.5) | 8 (61.5) | 13 (100.0) | ||
| Hypertensive hemorrhagic | 4 (66.7) | 2 (33.3) | 6 (100.0) | ||
| Non-hypertensive hemorrhagic | 1 (100.0) | 0 (0.0) | 1 (100.0) | ||
| Embolic | 4 (40.0) | 6 (60.0) | 10 (100.0) | ||
| CVT | 0 (0.0) | 3 (100.0) | 3 (100.0) | ||
| Onset, n (%) | |||||
| Witnessed | 24 (52.2) | 22 (47.8) | 46 (100.0) | 0.52 | |
| Unwitnessed | 11 (61.1) | 7 (38.9) | 18 (100.0) | ||
| Time to ER, median(range) | 24(239.50) | 24 (788) | 0.16a | ||
| Pandemic affected time to ER arrival, n (%) | |||||
| Yes | 11 (61.1) | 7 (38.9) | 18 (100.0) | 0.52 | |
| No | 24 (52.2) | 22 (47.8) | 46 (100.0) | ||
| Reasons for the delay, n (%) | |||||
| Delay finding vehicle | 7 (77.8) | 2 (22.2) | 9 (100.0) | ||
| Delay arranging family members | 0 (0.0) | 2 (100.0) | 2 (100.0) | ||
| Delay arranging finances | 2 (50.0) | 2 (50.0) | 4 (100.0) | ||
| Bed unavailability | 2 (66.7) | 1 (33.3) | 3 (100.0) | ||
| COVID-19 status, n (%) | |||||
| Positive | 3 (100.0) | 0 (0.0) | 3 (100.0) | 0.31b | |
| Negative | 31 (52.5) | 28 (47.5) | 59 (100.0) | ||
| Not examined | 1 (50.0) | 1 (50.0) | 2 (100.0) | ||
| NIHSS | 11.08±4.77 | 5.41±3.32 | 0.00 | ||
| NIHSS stroke severity, n (%) | |||||
| Minor | 1 (9.1) | 10 (90.9) | 11 (100.0) | 0.00 b | |
| Moderate | 27 (62.8) | 16 (37.2) | 43 (100.0) | ||
| Moderate to severe | 6 (100.0) | 0 (0.0) | 6 (100.0) | ||
| Normal | 1 (25.0) | 3 (75.0) | 4 (100.0) | ||
| Duration of hospital stay | 10.80±6.05 | 6.37±2.73 | 0.00 a | ||
| Progress during hospital stay, n (%) | |||||
| Improved | 21 (63.6) | 12 (36.4) | 33 (100.0) | 0.14 | |
| Static | 14 (45.2) | 17 (54.8) | 31 (100.0) | ||
| Regular physiotherapy at physio-center (n=60), n (%) | |||||
| Yes | 21 (65.6) | 11 (34.4) | 32 (100.0) | 0.02 | |
| No | 10 (35.7) | 18 (64.3) | 28 (100.0) | ||
| Regular physiotherapy at home (n=60), n (%) | |||||
| Yes | 19 (51.4) | 18 (48.6) | 37 (100.0) | 0.95 | |
| No | 12 (52.2) | 11 (47.8) | 23 (100.0) | ||
| Speech and swallowing expert consulted (n=60), n (%) | |||||
| Yes | 1 (50.0) | 1 (50.0) | 2 (100.0) | 1.00 | |
| No | 30 (51.7) | 28 (48.3) | 58 (100.0) | ||
| Able to follow-up (n=60), n (%) | |||||
| Yes | 20 (46.5) | 23 (53.5) | 43 (100.0) | 0.20 | |
| No | 11 (64.7) | 6 (35.3) | 17 (100.0) | ||
a
Mann–Whitney U test.
b
Fischer’s exact test.
CVT, cerebral venous thrombosis; ER, emergency room; LVO, large vessel occlusion; mRS, modified Rankin Scale; NIHSS, National Institute of Health Stroke Scale.
Bold value indicates outcome with significant P value.